Advertisement
Advertisement
Trending on CancerNetwork
1
104 KATSIS-1: Randomized Phase 3 Trial Evaluating KAT6 Inhibitor PF-07248144 (prifetrastat) Plus Fulvestrant in HR+HER2− Advanced/Metastatic Breast Cancer After Progression on CDK4/6 Inhibitor-Based Therapy
2
Nogapendekin Alfa Plus BCG Exhibits Efficacy Advantage in NMIBC in Situ
3
TIP103 Randomized Phase 3 Clinical Trial Evaluating Atirmociclib Plus Letrozole Versus a CDK4/6 Inhibitor Plus Letrozole as First-Line Treatment for Patients With HR+/HER2− Advanced/Metastatic Breast Cancer
4
Frontline Sevabertinib Earns FDA Priority Review in HER2-Mutated NSCLC
5